Chemical Name: 4-(2-Benzothiazolyl)-4-hydroxy-2,5-cyclohexadien-1-one
Biological ActivityPMX 464 is a putative inhibitor of the thioredoxin-thioredoxin reductase (Trx-TrxR) system. Shown to inhibit Trx and induce a G1/S block in HT29 cells; inhibits cell proliferation in various colorectal cancer cell lines and MCF7 cells. Also elicits an anti-inflammatory response in A549 cells.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.
Mukherjee et al.
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
Mukherjee et al.
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells.
Callister et al.
Citation for PMX 464
The citations listed below are publications that use Tocris products. Selected citations for PMX 464 include:
1 Citation: Showing 1 - 1
Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death
Sci Rep 2017;7:43168
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for PMX 464
There are currently no reviews for this product. Be the first to review PMX 464 and earn rewards!
Have you used PMX 464?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image